Breathlessness - Current and emerging mechanisms, measurement and management: A discussion from an European Association of Palliative Care workshop

Palliative Medicine

Volumn 27, Issue 10, 2013, Pages 932-938

  Currow, David C ^a   Higginson, Irene J ^b   Johnson, Miriam J ^c  

^a FLINDERS UNIVERSITY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

central modulation; clinical management; Dyspnoea; measurement; mechanism; peripheral modulation

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBON DIOXIDE; CREATINE; FUROSEMIDE; LACTIC ACID; MU OPIATE RECEPTOR; OPIATE; OXYGEN; POLYUNSATURATED FATTY ACID; PROMETHAZINE;

BREATH HOLDING; CENTRAL NERVOUS SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DYSPNEA; EXERCISE TOLERANCE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; HYPOXIA; MAGNETOENCEPHALOGRAPHY; MECHANORECEPTOR; META ANALYSIS (TOPIC); MOTOR ACTIVITY; MUSCLE FATIGUE; MUSCLE FUNCTION; NEUROIMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOTHERAPY; PLASTICITY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUADRICEPS FEMORIS MUSCLE; SENSATION; VISUAL ANALOG SCALE;

CENTRAL MODULATION; CLINICAL MANAGEMENT; DYSPNOEA; MEASUREMENT; MECHANISM; PERIPHERAL MODULATION;

DELIVERY OF HEALTH CARE; DYSPNEA; HUMANS; PALLIATIVE CARE; RESPIRATORY MUSCLES;

EID: 84888343802     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216313493819     Document Type: Conference Paper

References (54)

1. Johnson M, Bowden J, Abernethy AP, et al. To what clinical causes do patients attribute their breathlessness? A population survey. J Palliat Med. 2012 ; 15 (7). 744-750
2. Currow DC, Plummer J, Crockett A, et al. A community population survey of prevalence and severity of dyspnoea in adults. J Pain Symptom Manage. 2009 ; 38 (4). 533-545
3. Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnoea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage. 2010 ; 39 (4). 680-690
4. Tilden VP, Tolle SW, Drach LL, et al. Out-of-hospital death: advance care planning, decedent symptoms, and caregiver burden. J Am Geriatr Soc. 2004 ; 52 (4). 532-539
5. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage. :
6. Johnson MJ, Abernethy AP, Currow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?. J Pain Symptom Manage. 2012 ; 43 (3). 614-624
7. Abernethy AP, Wheeler JL, Currow DC. Common approaches to dyspnoea management in advanced life-limiting illness. Curr Opin Support Palliat Care. 2010 ; 4 (2). 53-55
8. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008 ; 2: CD005623
9. Booth S, Bausewein C, Higginson I, et al. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med. 2009 ; 3 (1). 21-36
10. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012 ; 185 (4). 435-452
11. Wheeler JL, Greene A, Tieman JJ, et al. Key characteristics of palliative care studies reported in the specialized literature. J Pain Symptom Manage. 2012 ; 43 (6). 987-992
12. Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neuroreport. 2000 ; 11 (10). 2117-2120
13. Moosavi SH, Golestanian E, Binks AP, et al. Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans. J Appl Physiol. 2003 ; 94 (1). 141-154
14. Von Leupoldt A, Dahme B. Experimental comparison of dyspnea and pain. Behav Res Methods. 2007 ; 39 (1). 137-143
15. Banzett RB, Adams L, O'Donnell CR, et al. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med. 2011 ; 184 (8). 920-927
16. Von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med. 2008 ; 177 (9). 1026-1032
17. Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol. 2002 ; 88 (3). 1500-1511
18. Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med. 2008 ; 177 (12). 1384-1390
19. Burgess KR, Whitelaw WA. Effects of nasal cold receptors on pattern of breathing. J Appl Physiol. 1988 ; 64 (1). 371-376
20. Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987 ; 136 (1). 58-61
21. Derry DD, Madsen CL, Rossdale M, et al. Use of a handheld fan and face-wipe speeds resolution of breathlessness in patients with chronic obstructive pulmonary disease but does not improve exercise capacity (Abstract). Eur Respir J. 2006 ; 28: 71s
22. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind randomized controlled trial (NCT00327873). Lancet. 2010 ; 376 (9743). 784-793
23. Bausewein C, Booth S, Gysels M, et al. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial 293. BMC Palliat Care. 2010 ; 9 (1). 22
24. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010 ; 39 (5). 831-838
25. Volterrani M, Clark AL, Ludman PF, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J. 1994 ; 15 (6). 801-809
26. Piepoli M, Clark AL, Volterrani M, et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation. 1996 ; 93 (5). 940-952
27. Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008 ; 8 (11). 887-899
28. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005 ; 8 (3). 265-269
29. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008 ; 3 (4). 637-658
30. Dudgeon DJ, Lertzman M. Dyspnea in the advanced cancer patient. J Pain Symptom Manage. 1998 ; 16 (4). 212-219
31. Broekhuizen R, Wouters EF, Creutzberg EC, et al. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax. 2005 ; 60 (5). 376-382
32. Fuld JP, Kilduff LP, Neder JA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax. 2005 ; 60 (7). 531-537
33. Bausewein C, Booth S, Higginson IJ. Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care. 2008 ; 2 (2). 95-99
34. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med. 2007 ; 21 (3). 177-191
35. Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 ; 94 (2). 149-158
36. Wijkstra PJ, TenVergert EM, Van Altena R, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994 ; 49: 465-467
37. Dorman S, Jolley C, Abernethy A, et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliat Med. 2009 ; 23 (3). 213-227
38. Currow DC, Abernethy AP, Johnson MJ. Activity as a measure of symptom control. J Pain Symptom Manage. 2012 ; 44: e1 - e2
39. Wilcock A, Walker G, Manderson C, et al. Use of upper limb exercise to assess breathlessness in patients with cancer: tolerability, repeatability, and sensitivity. J Pain Symptom Manage. 2005 ; 29 (6). 559-564
40. Williams M, Cafarella O, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest. 2008 ; 134 (3). 489-496
41. Johnson MJ, Oxberry SG, Cleland JG, et al. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. Eur J Heart Fail. 2010 ; 12 (2). 137-147
42. Uronis HE, McCrory DC, Samsa GP, et al. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011 ; 6: CD006429
43. Ben-Aharon I, Gafter-Gvili A, Paul M, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008 ; 26 (14). 2396-2404
44. Uronis HE, Currow DC, McCrory DC, et al. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008 ; 98 (2). 294-299
45. Clark AL, Johnson MJ, Squire I. Does home oxygen benefit people with chronic heart failure?. BMJ. 2011 ; 342: d234
46. Booth S, Moffat C, Burkin J, et al. Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011 ; 5 (2). 77-86
47. Rose C, Wallace L, Dickson R, et al. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Educ Couns. 2002 ; 47 (4). 311-318
48. Howard C, Dupont S, Haselden B, et al. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admissions in elderly patients with chronic obstructive pulmonary disease. Psychol Health Med. 2010 ; 15 (4). 371-385
49. Abernethy AP, Currow DC, Frith P, et al. Randomised double-blind placebo-controlled crossover trial of sustained-release morphine for the management of refractory dyspnoea. Br Med J. 2003 ; 327 (7414). 523-525
50. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011 ; 42 (3). 388-399
51. Newton P, Davidson PM, Macdonald P, et al. Nebulized furosemide for the management of dyspnea: does the evidence support its use?. J Pain Symptom Manage. 2008 ; 36 (4). 424-441
52. Farquhar MC, Prevost AT, McCrone P, et al. Study protocol: phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. Trials. 2011 ; 12: 130
53. Bausewein C, Jolley C, Reilly C, et al. Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial. BMC Pulm Med. 2012 ; 12: 58
54. Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. 2006 ; 14 (5). 444-453